OBJECTIVES: To evaluate the risk of incident physical disability and the decline in gait speed over a 6-year follow-up associated with a low ankle-arm index (AAI) in older adults. DESIGN: Observational cohort study. SETTING: Forsyth County, North Carolina; Sacramento County, California; Washington County, Maryland; and Allegheny County, Pennsylvania. PARTICIPANTS: Four thousand seven hundred five older adults, 58% women and 17.6% black, participating in the Cardiovascular Health Study. MEASUREMENTS: AAI was measured in 1992/93 (baseline). Self-reported mobility, activity of daily living (ADL), and instrumental activity of daily living (IADL) disability and gait speed were recorded at baseline and at 1-year intervals over 6 years of follow-up. Mobility disability was defined as any difficulty walking half a mile and ADL and IADL disability was defined as any difficulty with 11 specific ADL and IADL tasks. Individuals with mobility, ADL, or IADL disability at baseline were excluded from the respective incident disability analyses. RESULTS: Lower baseline AAI values were associated with increased risk of mobility disability and ADL/IADL disability. Clinical cardiovascular disease (CVD), diabetes mellitus, and interim CVD events partially explained these associations for mobility disability and clinical CVD and diabetes mellitus partially explained these associations for ADL and IADL disability. Individuals with an AAI less than 0.9 had on average a mean decrease in gait speed of 0.02 m/s per year, or a decline of 0.12 m/s over the 6-year follow-up. Prevalent CVD partly explained this decrease but interim CVD events did not further attenuate it. CONCLUSION: Low AAI serves as marker of future disability risk. Reduction of disability risk in patients with a low AAI should consider cardiovascular comorbidity and the prevention of additional disabling CVD events.
OBJECTIVES: To evaluate the risk of incident physical disability and the decline in gait speed over a 6-year follow-up associated with a low ankle-arm index (AAI) in older adults. DESIGN: Observational cohort study. SETTING: Forsyth County, North Carolina; Sacramento County, California; Washington County, Maryland; and Allegheny County, Pennsylvania. PARTICIPANTS: Four thousand seven hundred five older adults, 58% women and 17.6% black, participating in the Cardiovascular Health Study. MEASUREMENTS: AAI was measured in 1992/93 (baseline). Self-reported mobility, activity of daily living (ADL), and instrumental activity of daily living (IADL) disability and gait speed were recorded at baseline and at 1-year intervals over 6 years of follow-up. Mobility disability was defined as any difficulty walking half a mile and ADL and IADL disability was defined as any difficulty with 11 specific ADL and IADL tasks. Individuals with mobility, ADL, or IADL disability at baseline were excluded from the respective incident disability analyses. RESULTS: Lower baseline AAI values were associated with increased risk of mobility disability and ADL/IADL disability. Clinical cardiovascular disease (CVD), diabetes mellitus, and interim CVD events partially explained these associations for mobility disability and clinical CVD and diabetes mellitus partially explained these associations for ADL and IADL disability. Individuals with an AAI less than 0.9 had on average a mean decrease in gait speed of 0.02 m/s per year, or a decline of 0.12 m/s over the 6-year follow-up. Prevalent CVD partly explained this decrease but interim CVD events did not further attenuate it. CONCLUSION: Low AAI serves as marker of future disability risk. Reduction of disability risk in patients with a low AAI should consider cardiovascular comorbidity and the prevention of additional disabling CVD events.
Authors: Subashan Perera; Stephanie Studenski; Julie M Chandler; Jack M Guralnik Journal: J Gerontol A Biol Sci Med Sci Date: 2005-07 Impact factor: 6.053
Authors: A W Gardner; L I Katzel; J D Sorkin; D D Bradham; M C Hochberg; W R Flinn; A P Goldberg Journal: J Am Geriatr Soc Date: 2001-06 Impact factor: 5.562
Authors: A T Hirsch; M H Criqui; D Treat-Jacobson; J G Regensteiner; M A Creager; J W Olin; S H Krook; D B Hunninghake; A J Comerota; M E Walsh; M M McDermott; W R Hiatt Journal: JAMA Date: 2001-09-19 Impact factor: 56.272
Authors: A W Gardner; L I Katzel; J D Sorkin; L A Killewich; A Ryan; W R Flinn; A P Goldberg Journal: J Gerontol A Biol Sci Med Sci Date: 2000-10 Impact factor: 6.053
Authors: Mary McGrae McDermott; Kiang Liu; Philip Greenland; Jack M Guralnik; Michael H Criqui; Cheeling Chan; William H Pearce; Joseph R Schneider; Luigi Ferrucci; Lillian Celic; Lloyd M Taylor; Ed Vonesh; Gary J Martin; Elizabeth Clark Journal: JAMA Date: 2004-07-28 Impact factor: 56.272
Authors: Jay Giri; Mary M McDermott; Philip Greenland; Jack M Guralnik; Michael H Criqui; Kiang Liu; Luigi Ferrucci; David Green; Joseph R Schneider; Lu Tian Journal: J Am Coll Cardiol Date: 2006-02-09 Impact factor: 24.094
Authors: Roland J Thorpe; Anastasia J Wynn; Janiece L Walker; Jenny R Smolen; Michael P Cary; Sarah L Szanton; Keith E Whitfield Journal: J Natl Med Assoc Date: 2016-02 Impact factor: 1.798
Authors: M E M den Ouden; M J Schuurmans; I E M A Arts; D E Grobbee; M L Bots; A W van den Beld; S W J Lamberts; Y T van der Schouw Journal: J Nutr Health Aging Date: 2013-01 Impact factor: 4.075
Authors: Nora L Watson; Kim Sutton-Tyrrell; Ada O Youk; Robert M Boudreau; Rachel H Mackey; Eleanor M Simonsick; Caterina Rosano; Susan E Hardy; B Gwen Windham; Tamara B Harris; Samer S Najjar; Edward G Lakatta; Hal H Atkinson; Karen C Johnson; Douglas C Bauer; Anne B Newman; Anne B Nemwan Journal: Am J Hypertens Date: 2010-09-09 Impact factor: 2.689
Authors: Michelle C Odden; Laura M Yee; Alice M Arnold; Jason L Sanders; Calvin Hirsch; Christopher deFilippi; Jorge R Kizer; Marco Inzitari; Anne B Newman Journal: J Am Geriatr Soc Date: 2014-09 Impact factor: 5.562
Authors: Rosemarie Met; Jim A Reekers; Mark J W Koelemay; Dink A Legemate; Rob J de Haan Journal: Health Qual Life Outcomes Date: 2009-10-12 Impact factor: 3.186
Authors: Andrew D Althouse; J Dawn Abbott; Kim Sutton-Tyrrell; Alan D Forker; Manuel S Lombardero; L Virginia Buitrón; Ivan Pena-Sing; Jean-Claude Tardif; Maria Mori Brooks Journal: Diabetes Care Date: 2013-06-04 Impact factor: 19.112
Authors: Andrew D Althouse; J Dawn Abbott; Alan D Forker; Marnie Bertolet; Emma Barinas-Mitchell; Rebecca C Thurston; Suresh Mulukutla; Victor Aboyans; Maria Mori Brooks Journal: Diabetes Care Date: 2014-03-04 Impact factor: 19.112
Authors: Alexis Elbaz; Martin J Shipley; Hermann Nabi; Eric J Brunner; Mika Kivimaki; Archana Singh-Manoux Journal: Int J Cardiol Date: 2013-12-29 Impact factor: 4.164